What's going on, everybody? It's episode 461 of the Genius Life.

What's going on, everybody?

Welcome back to another episode of the show.

I'm your host, Max Lugavir, journalist, filmmaker, and lifelong advocate for truth in health and wellness. And today, we're diving deep into a topic that's not just scientific, it's personal.

Investigative reporter Charles Pillar

joins me to expose the unsettling reality of fraud in Alzheimer's research. Charles is an

award-winning investigative correspondent for Science Magazine whose work has been nominated for a

Pulitzer Prize nine times. No big deal. His reporting has influenced national debates and

policies on Alzheimer's

research, forensic science, global health programs, and more. He's written for the New York Times,

The Washington Post, The Nation, and has testified before the U.S. Senate on transparency in research.

He's also the author of the new book, which just came out this week, doctored, fraud, arrogance,

and tragedy in the quest to cure Alzheimer's.

If you've ever wondered why billions of dollars have been poured into studies with little

to show for it, well, this conversation will blow your mind.

We're going to get into how scientific misconduct, especially the manipulation of amyloid protein research, has misled funding, shaped misguided drug approvals, and ultimately failed millions of families affected by this devastating disease.

We also discussed the FDA's controversial decisions and the growing interest in lifestyle changes and the rise of GLP1 agonist drugs as potential

game changers for cognitive health. This episode is about uncovering hard truths, but also about

hope. Listen all the way through to the end, you're not going to want to miss a beat. And as always,

if you find value in this conversation, share it with friends and loved ones. Before we dive in,

a quick favor, if you love this show, please consider taking a moment

to leave a rating and review on your podcast app of choice.

...